Follow us on social media
Chat with us
Home / Biohacking Academy / Foundations
FoundationsEvidence: Science foundations

What are peptides, and why is science so interested in them?

The science behind the molecules that let your cells communicate.

Listen to this articleAudio version
0:00 / 6:58
In this article

Welcome to the Peptogen Biohacking Academy. In this first module, we are going to answer an essential question: what are peptides, and why is science so interested in them?

Imagine your body is a city made of trillions of cells. Each one has specific functions, but to stay alive, they all need to communicate: some produce energy, others take part in the body's defenses, and others regulate metabolism. And here is a fascinating question: how does a cell know when it should carry out a particular function? The answer involves several biological communication systems, and among their key players we find some extraordinary molecules: peptides. Today we will look at what they are, how they work, and why they matter so much in research.

It all starts with amino acids

First, amino acids: the units used to build proteins and peptides. Imagine a set of letters. With those letters you can form words, and by changing their order, completely different messages. Something similar happens in our bodies: when two or more amino acids join through peptide bonds, they form a chain, and that chain can make up a peptide. What matters is this: the sequence defines the properties of the molecule, and changing a single amino acid can change its stability, its shape, or how it interacts with other molecules. That is why two peptides that look similar can have different biological functions.

How do peptides work inside the body?

The body uses several systems to transmit information, and some peptides are chemical messengers, while others take part in defense, regulation, or cell signaling. Imagine that each cell has locks called receptors, and that certain molecules interact with them and trigger responses. It is like a key in a lock, but not every key opens the same doors. Science calls this molecular interactions, receptor affinity, and cell signaling pathways. And one nuance: not all peptides act by activating receptors on the cell surface; some use other mechanisms. That diversity is what makes them so interesting to science.

An interesting biological mechanism, a promising experimental result, and a demonstrated clinical benefit are three different stages of scientific knowledge.

Your body already makes peptides naturally

They may sound like new laboratory substances, but they have been part of our biology long before biotechnology. Oxytocin, for example, is a peptide hormone linked to reproductive functions and social behavior. Glucagon, produced by the pancreas, helps regulate glucose availability. And GLP-1, an intestinal hormone, is related to glucose regulation, insulin secretion, and satiety. Those are just a few examples. By studying them, we are not only exploring artificial substances: we are understanding mechanisms that already exist in our biology.

Why do scientists develop peptides in laboratories?

Researchers study natural peptides and design synthetic molecules with specific characteristics. A natural molecule may break down quickly, and with chemical modifications, researchers investigate how to increase its stability or change how it interacts with receptors. One example is semaglutide, which acts on the GLP-1 receptor and shows how understanding a hormonal pathway makes it possible to design treatments that must then demonstrate efficacy and safety in clinical studies. But be careful: designing a molecule in the laboratory does not mean it is automatically safe or effective in humans. Only rigorous research can establish that.

What does it mean for a peptide to be under investigation?

This is one of the most important questions in the whole Academy. There are different levels of evidence: a molecule may be studied in cells, then in animals, and, if there is justification and the requirements are met, move on to clinical trials in humans. A good result in cells is a finding, but it does not prove the same thing happens in a person: the human body is far more complex than a cell culture. That is why we must distinguish three concepts: an interesting biological mechanism, a promising experimental result, and a demonstrated clinical benefit. They are different stages of knowledge, and understanding that protects us from exaggerating research results.

Why are peptides generating so much interest right now?

Because they are a very versatile platform: they are being investigated in endocrinology, metabolism, oncology, and infectious diseases, among other areas. Some molecules are already approved medicines, others remain in clinical investigation, and many are only studied at experimental stages. And there are challenges: some break down quickly, struggle to cross certain barriers, or need special delivery systems, and their adverse effects, interactions, and immunological risks must be studied. Investigating peptides is not only about discovering molecules: it is about understanding how they behave, how they are produced, how they are analyzed, and what evidence supports them.

The question we should be asking

  • With this, we look at peptides with different eyes: it is no longer about hearing a name and asking what benefits it promises, but about asking smarter questions. What type of peptide is it?
  • What biological mechanism is being investigated?
  • What studies support it?
  • Are there clinical results in humans?
  • Are its risks and limitations known?

That is the difference between consuming information and having scientific judgment, the purpose of this Academy. We do not want you to memorize complicated names: we want you to understand the science behind them.

In summary

peptides are short chains of amino acids whose sequence defines their properties; your body already makes them; designing a molecule does not automatically make it safe or effective; and a mechanism, a result, and a demonstrated benefit are three different stages of evidence.

And now that we know what a peptide is, the next question arises: how can such a small molecule send a signal that triggers a response inside a cell? That will be our next module: the fascinating world of cell receptors. This was the Peptogen Biohacking Academy. Educational content only; it does not constitute medical advice.

References

  1. Alberts B, et al. <i>Molecular Biology of the Cell.</i> Garland Science.
  2. Lau JL, Dunn MK. Therapeutic peptides: historical perspectives, current development trends, and future directions. <i>Bioorganic &amp; Medicinal Chemistry</i>, 2018.
  3. Muttenthaler M, et al. Trends in peptide drug discovery. <i>Nature Reviews Drug Discovery</i>, 2021.
  4. PubChem (NIH): compound records and biological pathways.

This article is for educational and research purposes only. Peptogen products are research-grade compounds intended exclusively for laboratory and in-vitro research. They are not for human or animal consumption, diagnostic or therapeutic use, and nothing here constitutes medical advice or dosing guidance.

Keep reading

More from the Academy

All articles